Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis
This meta-analysis evaluated the association between growth hormone replacement therapy (GHRT) and the risk of tumor recurrence or progression in patients with intracranial tumors. Analyzing 15 studies encompassing over 2,232 cases and 3,606 controls, the study found that GHRT was not linked to an increased risk of tumor recurrence or
June 26, 2025
No Comments